Dauriporphine

Dauriporphine
Product Name Dauriporphine
CAS No.: 88142-60-3
Catalog No.: CFN92921
Molecular Formula: C20H17NO5
Molecular Weight: 351.35 g/mol
Purity: >=98%
Type of Compound: Alkaloids
Physical Desc.: Powder
Targets: NF-kB | P-gp
Source: The roots of Euchresta japonica
Solvent: Chloroform, Dichloromethane, Ethyl Acetate, DMSO, Acetone, etc.
Price:
Dauriporphine shows cytotoxic activity on the target cancer cell lines, and shows significant angiogenesis inhibitions. Dauriporphine shows significant inhibitions on receptor activator of nuclear factor-κB ligand-induced differentiation of mouse bone marrow-derived macrophages into multinucleated osteoclasts. Dauriporphine shows potent P-gp MDR inhibition activity with an ED50 value 0.03 microg/mL and 0.00010 microg/mL in the MES-SA/DX5 and HCT15 cells, respectively.
Inquire / Order: manager@chemfaces.com
Technical Inquiries: service@chemfaces.com
Tel: +86-27-84237783
Fax: +86-27-84254680

Address:
1 Building, No. 83, CheCheng Rd., Wuhan Economic and Technological Development Zone, Wuhan, Hubei 430056, PRC
Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 24 months(2-8C).

Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.

Need more advice on solubility, usage and handling? Please email to: service@chemfaces.com

The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.
  • Korean Journal of Pharmacognosy.2020, 51(2):100-106
  • Evid Based Complement Alternat Med.2017, 2017:1583185
  • Anal Chim Acta.2018, 1039:162-171
  • Eur J Pharmacol.2020, 889:173589.
  • Nutraceuticals2022, 2(3),150-161
  • Biomed Pharmacother.2023, 163:114785.
  • Int J Nanomedicine.2022, 17:6513-6525.
  • Journal of Functional Foods2022, 99: 105331.
  • Aging (Albany NY).2021, 13(19):22867-22882.
  • Regen Biomater.2023, 10:rbad077.
  • Dauriporphine

    Catalog No: CFN92921
    CAS No: 88142-60-3
    Price: Inquiry(manager@chemfaces.com)
    Dauriporphinoline

    Catalog No: CFN92919
    CAS No: 100009-82-3
    Price: Inquiry(manager@chemfaces.com)
    Menisporphine

    Catalog No: CFN92920
    CAS No: 83287-02-9
    Price: Inquiry(manager@chemfaces.com)
    Clopidogrel Related Compound A

    Catalog No: CFN90546
    CAS No: 144457-28-3
    Price: Inquiry(manager@chemfaces.com)
    Clopidogrel Related Compound B

    Catalog No: CFN90547
    CAS No: 144750-52-7
    Price: Inquiry(manager@chemfaces.com)
    Clopidogrel Related Compound C

    Catalog No: CFN90548
    CAS No: 120202-71-3
    Price: Inquiry(manager@chemfaces.com)
    Arch Pharm Res. 2016 May;39(5):713-20.
    Anti-osteoclastogenic effects of isoquinoline alkaloids from the rhizome extract of Sinomenium acutum.[Pubmed: 26992921]

    METHODS AND RESULTS:
    A phytochemical investigation for the rhizome extract from Sinomenium acutum (Menispermaceae) resulted in the isolation of several active principles responsible for the anti-osteoclastogenic property of the extract, together with related isoquinoline alkaloids (1-13) including two new compounds, 1 and 2. Among isolated compounds, salutaridine (7), dauricumine (10), cheilanthifoline (12), and Dauriporphine (13) were observed to give significant inhibitions on receptor activator of nuclear factor-κB ligand-induced differentiation of mouse bone marrow-derived macrophages into multinucleated osteoclasts, respectively.
    CONCLUSIONS:
    The chemical structures of two newly isolated compounds, 1 and 2 were established as 8-demethoxycephatonine (1) and 7(R)-7,8-dihydrosinomenine (2), by spectroscopic analyses including 2D NMR experiments.
    Arch Pharm Res. 2006 Aug;29(8):627-32.
    Aporphine alkaloids and their reversal activity of multidrug resistance (MDR) from the stems and rhizomes of Sinomenium acutum.[Pubmed: 16964757]

    METHODS AND RESULTS:
    Chromatographic separation of the MeOH extract from the stems and rhizomes of Sinomemium acutum led to the isolation of nine alkaloids and a lignan. Their structures were determined to be Dauriporphine (1), bianfugecine (2), dauriporphinoline (3), menisporphine (4), (-)-syringaresinol (5), N-feruloyltyramine (6), acutumine (7), dauricumine (8), sinomenine (9), and magnoflorine (10) by spectroscopic means. These compounds were examined for their P-gp mediated MDR reversal activity in human cancer cells.
    CONCLUSIONS:
    Compound 1 showed the most potent P-gp MDR inhibition activity with an ED50 value 0.03 microg/mL and 0.00010 microg/mL in the MES-SA/DX5 and HCT15 cells, respectively.
    Planta Med. 2012 Nov;78(17):1873-7.
    New alkaloids and cytotoxic principles from Sinomenium acutum.[Pubmed: 23059629]

    METHODS AND RESULTS:
    Two new alkaloids, 2-demethyl-oxypalmatine (1) and 5-ethoxycarbonylsinoracutine (2), were isolated from the rhizomes of Sinomenium acutum, along with thirty-four known compounds. Cytotoxicity of the isolated compounds was examined for the MCF-7, H460, HT-29, and CEM human cancer cell lines.
    CONCLUSIONS:
    Dauriporphine (16), 6-O-demethylmenisporphine (17), bianfugecine (18), menisporphine (19), and 6-O-demethylDauriporphine (20) showed differential effects in their cytotoxic activity on the target cancer cell lines. Significant angiogenesis inhibitions of 16 and 19 were also observed.
    Poricoic acid B

    Catalog No: CFN95050
    CAS No: 137551-39-4
    Price: $318/20mg
    Marginatoxin

    Catalog No: CFN95174
    CAS No: 1422536-56-8
    Price: $318/10mg
    19-O-beta-D-carboxyglucopyranosyl-12-O-beta-D-glucopyranosyl-11,16-dihydroxyabieta-8,11,13-triene

    Catalog No: CFN95217
    CAS No: 1011714-20-7
    Price: $318/5mg
    Gypenoside XIII

    Catalog No: CFN95239
    CAS No: 80325-22-0
    Price: $288/10mg
    Diosniposide B

    Catalog No: CFN95333
    CAS No: N/A
    Price: $413/5mg
    Maingayone

    Catalog No: CFN95479
    CAS No: 271585-66-1
    Price: $318/10mg
    Isorhamnetin-3-O-rutinoside-7-O-glucoside

    Catalog No: CFN95494
    CAS No: 55481-91-9
    Price: $318/5mg
    trans-Cinnamoyl beta-D-glucoside

    Catalog No: CFN95497
    CAS No: 13080-39-2
    Price: Inquiry(manager@chemfaces.com)
    New compound 21

    Catalog No: CFN95560
    CAS No: N/A
    Price: $413/5mg
    8-Hydroxy-5,7-dimethoxyflavanone

    Catalog No: CFN95580
    CAS No: 201230-40-2
    Price: $318/5mg